Iridex Corp
IRIX- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001006045
In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Iridex Corp changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 22 | 1 | 25 | +4 |
| Shares | 2.79M | 578.7K | 2.89M | +680.5K (+30.8%) |
| Value | $3.19M | $659.7K | $2.92M | +$395.4K (+15.7%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Iridex Corp at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 514,593 | $519.7K | 0.00% |
| Vanguard Fiduciary Trust Co | 60,155 | $60.8K | 0.00% |
| Diversify Wealth Management, LLC | 33,840 | $34.9K | 0.00% |
| Two Sigma Securities, LLC | 10,792 | $10.9K | 0.00% |
| Vanguard Global Advisers, LLC | 3,963 | $4.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,092 | $2.11K | 0.00% |
| UBS Group AG | 1,144 | $1.16K | 0.00% |
Sold out (3)
Institutions that held Iridex Corp at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| XTX Topco Ltd | 28,494 | $32.5K |
| Diversify Advisory Services, LLC | 19,134 | $27.0K |
| Bank of America Corp | 127 | $144 |
Not filed for Q1 2026 yet (1)
Institutions that held Iridex Corp at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 578,711 | $659.7K |